$QNTBullishMed

Quantinuum prices its IPO at $1.68bn, setting a new bar for quantum

Quantinuum, backed by Honeywell, priced its Nasdaq IPO at $60 per share, above the marketed $53–$55 range, raising about $1.68bn by selling 28m shares (upsized from 26.5m), according to Reuters. The deal values the firm at about $15.6bn. It trades Thursday under ticker QNT.

Med
Bullish
IPO pricing and first trading day on Nasdaq (Thursday)
Demand appears stronger than bankers’ marketed range, aligning with a risk-on IPO bid

IPO pricing above the marketed range signals strong demand and sets an initial valuation benchmark for quantum peers.

Quantinuum priced its Nasdaq IPO at $60 (vs $53–$55 marketed range), valuing it ~$15.6bn and starting trading Thursday under QNT.

Near-term positive bias for first-session trading; volatility likely as investors reprice the long-duration, low-revenue story.

Background

Quantinuum formed in 2021 from Honeywell’s quantum business and Cambridge Quantum; it is working toward a fault-tolerant machine called Apollo targeted for 2029.

Why it matters

The key tradable development is the IPO’s final pricing ($60) and the resulting valuation benchmark, which can drive initial flows and peer read-through in quantum.

Market relevance

A large, above-range quantum IPO sets the first public-market valuation anchor for the sector and frames near-term investor positioning for QNT.

Market effects

Creates a valuation reference point for quantum-computing listings and may influence expectations for future quantum IPOs/SPACs.

Primarily US/Nasdaq sentiment for high-growth tech/IPO appetite; limited direct regional transmission beyond IPO flow.

Benchmarking effect for international quantum funding and investor risk appetite toward pre-revenue deep-tech.

Alternative perspectives

The above-range IPO price may reflect one-day IPO momentum rather than durable fundamentals, given Apollo is targeted for 2029 and revenue is modest.

Post-listing performance will hinge on early commercialization milestones, burn rate, and whether investors treat the valuation as a sector multiple or a one-off demand spike.

Key entities

  • Quantinuum

    IPO priced at $60, upsized to 28m shares, begins trading on Nasdaq Thursday under ticker QNT.

  • Honeywell

    Backs Quantinuum through the offering and is expected to hold ~49% of voting power afterward.

Related articles

$QNTMed

Quantinuum Announces Closing of Upsized Initial Public Offering

Quantinuum Inc. (Nasdaq: QNT) said it has closed an upsized IPO of 28,000,000 shares of Class A common stock at $60.00 per share. The company reported $1.68 billion in gross proceeds before underwriting discounts and expenses. The SEC declared the registration statement effective June 3, 2026. J.P. Morgan and Morgan Stanley led the offering.

$UALLow

13 Top Press Releases from May

PR Newswire’s June 5 recap highlights May press releases including United’s offer of price-capped one-way tickets for Spirit customers after flight cancellations, and eBay’s rejection of an unsolicited GameStop proposal. It also notes Lilly’s Phase 3 retatrutide obesity results, a telecom satellite joint venture, and other corporate updates, plus May holiday and earnings-related trends.

$QNTMed

Benzinga

Quantinuum Inc (NASDAQ: QNT) began trading on its first Nasdaq session at $68 per share, up 13.3% from its $60 IPO price on 28 million shares, according to Benzinga. Pre-market indications ranged from about $61.50 to a peak near $78 before stabilizing at $68 for the opening print, reflecting strong institutional and retail demand.

$QNTMed

Quantinuum Sends Qnt Stock Toward Nasdaq Debut and $14.3 Billion

Quantinuum, a Honeywell-backed quantum computing company, is preparing for a Nasdaq debut and is seeking a valuation of up to $14.3 billion, according to the article. The planned offering could be among the largest in the sector, and traders may use its pricing as a reference point for other quantum stocks ahead of listing.

$QNTMed

Quantum Computing Shares Sink Ahead Of Blockbuster Quantinuum IPO

Quantinuum (QNT) shares fell Wednesday as the Honeywell-backed firm neared its Nasdaq debut, with pricing set for June 3 and first trading expected June 4. The company plans to sell 26.5 million shares at $53–$55 to raise about $1.46 billion, valuing it at up to $14.3 billion, according to the report. Other quantum stocks also declined.